If you are seeing this message, there was a problem loading the default style. Please click one of the Text Sizes below, which will fix this issue.
News
October 26, 2007

Smoking, dopamine and mental illness
Full Story | News Archive | Topics: , , ,

Nicotine has long been known to be a risk factor for cardiovascular disease and cancer, but it also is a gateway to substance abuse and marijuana, and a factor in mental illness. The National Center on Addiction and Substance Abuse at Columbia University has now published Tobacco -- The Smoking Gun (for purchase or free pdf download) discussing the damage done to the adolescent brain.



Anxiety symptoms are stronger for smokers than for non-smokers, and twice as many (22 percent) nicotine-dependent people with anxiety disorders smoke compared to the general population (11 percent). But the direction of smoking and illness is not always clear. Some studies indicate that while smoking “points to an increased risk of depression,” depression might also be a risk factor for smoking.



Animal studies suggest that nicotine exposure causes serotonin impairment, and people with depression have “a decrease in these receptors.” Nicotine also produces neurochemical reactions in the developing brain including an increased amount of dompamine.



   Post a Comment

MIWatch would love to hear your thoughts. Please join the discussion.


characters left

Text Size default medium big large
Consider This

Who gets the (Medicare) advantage?
by Phyllis Vine

Mental health reform needs input
by Phyllis Vine

Goodwin under the bus
by Phyllis Vine

Local ballot boxes '08
by Phyllis Vine

PARITY PASSES -- Kudos
by Phyllis Vine

Full Consider This Archives

Subscribe via Email
Browse by Topic
MIWatch Archives
Recent Columns

Commentary
Coming off medications: A harm reduction approach
by Will Hall

Commentary
Overcrowded psychiatric emergency rooms
by Anthony T. Ng

Interviews
Q & A with Ron Manderscheid: agenda for reform
by Phyllis Vine

Commentary
Helping college students: PADs on campus
by Anna Scheyett

Commentary
Graduate school and mental illness...intertwined needs and success
by KR.Avilés-Vázquez

Commentary
Economic Security: Key to Recovery and Self-Determination
by Judith A. Cook

Commentary
A proposal for transitional crisis beds
by Sol Wachtler

Commentary
Psychiatric Advance Directives: A tool for patients and clinicians
by Marvin Swartz

Commentary
Access to care: training consumers and case managers
by Jack Carney

Commentary
Race, genetics, metabolism: drug therapy and clinical trials
by L. DiAnne Bradford

Full Columnist Listing

Reviews

Reform medicine, say authors
by Phyllis Vine

"Another Kind of VALOR"
by Phyllis Vine

"A Fight To Be," Ronald Bassman, Ph.D.
by Paul Pines

"Comfortably Numb: How Psychiatry is Medicating a Nation," Charles Barber
by Alison Bateman-House

"The Insanity Offense," E. Fuller Torrey
by Sue E. Estroff, Ph.D.